DIANNE MARGARET COOPER M.D. NPI 1649232810

NPI Information

  • NPI: 1649232810
  • Provider Name: DIANNE MARGARET COOPER, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4412 KELL BLVD
    WICHITA FALLS, TX
    ZIP 76309
  • Phone: (940) 692-1200

Map and Directions

Get Directions

NPI Details

Dianne Margaret Cooper, M.D. is a rheumatology internal medicine in Wichita Falls, TX with 28 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Dianne Margaret Cooper, M.D. NPI is 1649232810. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE
Graduation Year:1998

The provider's business location address is:

4412 KELL BLVD
WICHITA FALLS, TX
ZIP 76309-719
Phone: (940) 692-1200

The NPI 1649232810 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, belimumab, 10 mg (HCPCS:J0490)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg (HCPCS:J7325)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Fluoroscopic guidance for needle placement (HCPCS:77002)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Biopsy of related skin growth, first growth (HCPCS:11102)
  • Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Destruction of skin growth, 1-14 growths (HCPCS:17110)
  • Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection into tendon or ligament (HCPCS:20550)

The enumeration date for this NPI number is 4/4/2006 and was last updated on 11/28/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyL6840TEXASYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.